NCT01171014

Effect of Bifidobacterium Lactis HN019 on Colonic Transit Time and Digestive Symptoms

A Three-Arm, Placebo Controlled, Double-Blind, Single Center Study to Evaluate the Impact of Probiotic Strain Bifidobacterium Lactis HN019 on Intestinal Well-Being, Colonic Transit Time and Digestive Discomfort

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Fonterra Research Centre · Industry
• Sex: All
• Age: 25 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study was to investigate the dose response effect of Bifidobacterium lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms.

Conditions

• Gastrointestinal Symptoms

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Bifidobacterium lactis HN019	Bifidobacterium lactis HN019, 10 billion cfu/day, once a day for 14 days
DIETARY_SUPPLEMENT	Bifidobacterium lactis HN019	Bifidobacterium lactis HN019, 1 billion cfu/day, once a day for 14 days
DIETARY_SUPPLEMENT	Placebo	Placebo, once a day for 14 days

Timeline

• Start date: 2009-06-01
• Primary completion: 2009-12-01
• Completion: 2009-12-01
• First posted: 2010-07-28
• Last updated: 2010-07-28